Snyderman to Get NC Life Science Award


Ralph Snyderman, M.D., chancellor emeritus at Duke University and James B. Duke Professor of Medicine, will receive the 2014 Life Science Leadership Award on Thursday, Feb. 27, for his contributions to the field in North Carolina.

The award will be given by the North Carolina Biotechnology Center, NCBIO and the Council for Entrepreneurial Development (CED) during the closing lunch at the two-day CED Life Science Conference 2014 at the Raleigh Convention Center.

Snyderman served as chancellor for health affairs and dean of the School of Medicine from 1989 to 2004, while commissioning and overseeing the development of the Duke University Health System. For two years before joining Duke, he served as vice president of medical research and development for Genentech, a biomedical technology firm in San Francisco.

His research interests lie in the development of genetic and biochemical techniques for the study of leukocyte activation. He played a leading role in the conception and development of prospective care, an approach to personalized health and an evolving model of national health delivery.

 “The fact that Ralph Snyderman has been called ‘the father of personalized medicine’ reflects the pivotal role he has played in this increasingly important field,” said Norris Tolson, president and CEO of the North Carolina Biotechnology Center, a conference co-sponsor. “For this and for his many other contributions to the life sciences in our state, it is fitting that his name be added to those who have led the field and received this award continuously since 2002.”

Sam Taylor, president of NCBIO, which also sponsors the annual conference, added that Snyderman deserved the award because he “understands the importance of the industry in developing drugs and devices that cannot only improve the lives of individuals but the overall quality of health care."

For questions or more information, contact:
Jim Shamp
Director of Public Relations

Corporate Communications

919-549-8889 |

Thu, 02/20/2014 - 00:00